• Eastman Chemical's consensus price target has fluctuated over the past year, indicating changing analyst expectations.
• The company is expected to report a decline in earnings for the fourth quarter of 2025, with forecasts of $0.79 per share and $2 billion in revenue.
• Despite a 23% decline in stock value over the past year, Eastman Chemical's valuations and dividends remain attractive to investors.

Eastman Chemical Company (NYSE: EMN) is a mid-cap company in the basic materials sector, known for its specialty materials and chemicals. It competes with companies like Tosoh and Akzo Nobel. Over the past year, Eastman Chemical's consensus price target has seen some fluctuations, reflecting changes in analysts' expectations for the company's stock performance.

Last month, the average price target for Eastman Chemical was $72, slightly higher than the previous quarter's $71.33. A year ago, the target was $73.43, indicating a gradual decrease over the year. This trend suggests that analysts have adjusted their expectations, possibly due to various factors affecting the company's performance.

Earnings reports play a crucial role in shaping analysts' price targets. Eastman Chemical is expected to report its fourth-quarter 2025 earnings on January 29th, with forecasts of $0.79 per share and $2 billion in revenue. However, analysts predict a decline in earnings, which could influence future price targets. Wolfe Research has set a price target of $114, reflecting their expectations for the company's growth.

Market conditions also impact Eastman Chemical's performance. The company operates in key markets like transportation, personal care, and construction, which are influenced by economic factors. Despite a 23% decline in stock value over the past year, Eastman Chemical's valuations and dividends remain attractive, making it a potential investment opportunity.

Strategic initiatives and product developments can further affect analysts' views. Eastman Chemical's annual dividend payments are a significant factor for income-focused investors. Wolfe Research's $114 price target indicates a positive outlook, suggesting that strategic moves could enhance the company's stock performance in the future.